<div id="readability-page-1">03:58 PM EST, 12/10/2025 (MT Newswires) -- Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index adding 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) gaining 1.4%.The iShares Biotechnology ETF (IBB) increased 1.3%.In corporate news, CVS Health ( CVS ) is entering 2026 with momentum and visibility into mid-teens earnings growth through 2028 on margin and operational improvements, RBC Capital Markets said. CVS shares rose 1%.Pfizer ( PFE ) plans to cut more than 200 jobs in Switzerland as part of its multiyear cost reduction program, Bloomberg reported. Pfizer ( PFE ) shares gained 1.7%.HeartBeam ( BEAT ) shares almost doubled after the company said the US Food and Drug Administration has granted a 510(k) clearance for its 12-lead electrocardiogram synthesis software for use at home or anywhere to assess arrhythmia.Centessa Pharmaceuticals ( CNTA ) is positioned to redefine narcolepsy treatment with its pipeline that includes best-in-class orexin agonists, Oppenheimer said, boosting its price target on the stock to $62 from $40. Centessa shares rose 3.5%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

西维斯

CNTA

医疗保健股票在下午交易中上涨，纽约证券交易所医疗保健指数上涨 1.6%，State Street 医疗保健精选行业 SPDR ETF 上涨 1.4%。CVS Health 预计到 2028 年将实现中双位数的盈利增长，推动其股价上涨 1%。辉瑞计划在瑞士裁员，股价上涨 1.7%。HeartBeam 的股价在获得 FDA 对其心电图软件的批准后几乎翻倍。Centessa Pharmaceuticals 的股价在 Oppenheimer 上调目标价后上涨 3.5%

板块更新：医疗保健类股在下午晚些时候上涨